[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amphastar Pharma (AMPH)

Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 907,434
  • Shares Outstanding, K 44,093
  • Annual Sales, $ 719,890 K
  • Annual Income, $ 98,090 K
  • EBIT $ 117 M
  • EBITDA $ 177 M
  • 60-Month Beta 0.89
  • Price/Sales 1.23
  • Price/Cash Flow 4.74
  • Price/Book 1.16

Options Overview Details

View History
  • Implied Volatility 84.30% (+8.16%)
  • Historical Volatility 49.33%
  • IV Percentile 76%
  • IV Rank 41.96%
  • IV High 151.74% on 03/23/26
  • IV Low 35.55% on 08/18/25
  • Expected Move (DTE 22) 1.83 (8.97%)
  • Put/Call Vol Ratio 0.40
  • Today's Volume 215
  • Volume Avg (30-Day) 122
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 2,001
  • Open Int (30-Day) 1,108
  • Expected Range 18.55 to 22.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.51
  • Number of Estimates 1
  • High Estimate $0.51
  • Low Estimate $0.51
  • Prior Year $0.75
  • Growth Rate Est. (year over year) -32.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.41 +10.70%
on 07/14/26
20.70 -1.55%
on 07/29/26
+0.20 (+0.99%)
since 06/30/26
3-Month
16.65 +22.44%
on 05/18/26
24.34 -16.29%
on 05/07/26
-1.58 (-7.19%)
since 04/30/26
52-Week
16.65 +22.44%
on 05/18/26
31.26 -34.81%
on 09/02/25
-0.96 (-4.50%)
since 07/30/25

Most Recent Stories

More News
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

RANCHO CUCAMONGA, Calif. , July 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its second quarter of 2026 ended...

AMPH : 20.38 (-0.97%)
1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds

1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds

LSCC : 124.53 (+10.24%)
RELY : 23.45 (+0.69%)
AMPH : 20.38 (-0.97%)
3 Reasons AMPH is Risky and 1 Stock to Buy Instead

3 Reasons AMPH is Risky and 1 Stock to Buy Instead

AMPH : 20.38 (-0.97%)
3 Stocks Under $50 We Keep Off Our Radar

3 Stocks Under $50 We Keep Off Our Radar

AR : 35.30 (+0.46%)
AMPH : 20.38 (-0.97%)
CLMT : 43.75 (+3.18%)
1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges

1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges

ARLO : 14.47 (-0.28%)
AMPH : 20.38 (-0.97%)
CME : 267.22 (+0.67%)
1 Healthcare Stock to Consider Right Now and 2 We Brush Off

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

AMPH : 20.38 (-0.97%)
WAT : 380.30 (+0.22%)
RDNT : 62.69 (-1.07%)
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives told investors at the Jefferies Healthcare Conference that the company is maintaining expectations for mid- to high-single-digit revenue growth in 2026,...

AMPH : 20.38 (-0.97%)
3 Stocks Under $50 with Open Questions

3 Stocks Under $50 with Open Questions

GCO : 38.60 (-1.23%)
AMPH : 20.38 (-0.97%)
SNDR : 34.14 (-3.18%)
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today

Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today

AMPH : 20.38 (-0.97%)
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives said the company is taking steps to address rebate and discounting pressure on BAQSIMI while maintaining its full-year revenue outlook, according to remarks...

AMPH : 20.38 (-0.97%)

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

3rd Resistance Point 21.19
2nd Resistance Point 20.86
1st Resistance Point 20.62
Last Price 20.38
1st Support Level 20.05
2nd Support Level 19.71
3rd Support Level 19.47

See More

52-Week High 31.26
Fibonacci 61.8% 25.68
Fibonacci 50% 23.95
Fibonacci 38.2% 22.23
Last Price 20.38
52-Week Low 16.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.